Your browser doesn't support javascript.
loading
Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia.
Reikvam, Håkon; Dillon, Richard.
Affiliation
  • Reikvam H; K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Dillon R; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Expert Rev Hematol ; 17(4-5): 103-106, 2024.
Article in En | MEDLINE | ID: mdl-38654593
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Neoplasm, Residual / Fms-Like Tyrosine Kinase 3 / Mutation Limits: Humans Language: En Journal: Expert Rev Hematol Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Noruega
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Neoplasm, Residual / Fms-Like Tyrosine Kinase 3 / Mutation Limits: Humans Language: En Journal: Expert Rev Hematol Journal subject: HEMATOLOGIA Year: 2024 Document type: Article Affiliation country: Noruega